Drug transporters can be major determinants of pharmacokinetics, drug-drug interactions, and the safety and efficacy of drugs. At Frontage, we have extensive experience in transporter research. We offer comprehensive transporter services to support projects from discovery to development, including screening and full characterization in both uptake and efflux transporter.
Register to gain access to gated resources.
Thank you for registering!
You now have the option of downloading the resource or viewing the web version below.
This study is aimed at developing a Nanoemulsion formulation of a poorly water-soluble and thermally, oxidatively, and photolytically unstable active pharmaceutical ingredient (API) for ophthalmic application, specifically for the reduction of intraocular pressure (IOP) and to provide neuroprotection.
This discussion focuses on the challenges of global drug development and the long-term implications of COVID-19.
Frontage has developed a next-generation sequencing (NGS)-based method to rapidly determine the genotype of 300+ genes involved in ADME, called the Frontage PGx NGS Test.